Figure 1From: DPP-4 inhibitor and alpha-glucosidase inhibitor equally improve endothelial function in patients with type 2 diabetes: EDGE studyStudy protocol. The patients were followed for at least 8Â weeks to confirm that they did not achieve the treatment goal. The patients were prospectively, randomly assigned to additional treatment with either sitagliptin (50Â mg/day) or voglibose (0.6Â mg/day) for 12Â weeks. Measurements of flow-mediated dilatation (FMD) of the brachial artery and blood and urine tests were performed in the fasting state at baseline and after 12Â weeks of treatment.Back to article page